Related Experiment Video
Updated: Jul 6, 2026
09:44
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
Taking aim at translation for tumor therapy.
Bryan C Barnhart1, M Celeste Simon
1Abramson Family Cancer Research Institute, University of Pennsylvania Cancer Center, Pennsylvania 19104, USA.
The Journal of Clinical Investigation
|September 6, 2007
Summary
Researchers found that targeting the cap binding protein eukaryotic translation initiation factor 4E (eIF4E) with antisense oligonucleotides showed significant antitumor effects. This approach may offer a promising new cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Increased cap-dependent mRNA translation is common in human cancers.
- Overexpression of eukaryotic translation initiation factor 4E (eIF4E), a cap binding protein, enhances the translation of tumor-promoting genes in many human tumors.
Discussion:
- Graff and colleagues investigated the therapeutic potential of second-generation antisense oligonucleotides targeting eIF4E.
- This strategy aims to inhibit cancer cell growth by downregulating eIF4E activity and consequently reducing the translation of oncogenic mRNAs.
Key Insights:
- Antisense oligonucleotides targeting eIF4E demonstrated potent antitumor effects in preclinical studies.
- This targeted inhibition strategy offers a novel approach to cancer therapy by disrupting a critical mechanism of cancer progression.
Outlook:
- Successful recapitulation of these findings in clinical settings could establish eIF4E-targeted antisense oligonucleotides as a promising new cancer treatment.
- This therapeutic strategy holds potential for broad-reaching applications across various human cancers.
Related Concept Videos
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.